Professor Lee is the current Dean of the College of Healthcare and an attending physician in the Department of Neurology at China Medical University Hospital. Professor Lee is an expert in Wilson's disease.

Professor Woei-Cheang Shyu is the Vice President of China Medical University Hospital and an attending physician in the Neurology Department. He has long been dedicated to research in neuroimmunology, stem cells, exosomes, and basic neurology. He is one of the few neurologists with a strong foundation in basic neuroscience research. His work in translating stem cell research into clinical treatment is unparalleled globally and has significantly benefited patients. With his support, there are currently Phase I clinical research projects underway in the Neurology Department for subacute ischemic stroke and multiple sclerosis, making him a key driver of innovation and breakthroughs in neurology.

Dr. Lane Hsien-Yuan specializes in the treatment of schizophrenia, bipolar disorder, depression, and dementia. His team is dedicated to discovering safer natural compounds for the treatment of psychiatric disorders and has received prestigious national and international awards for their work.

Dr. Pei-Ying Pai was a researcher in the Mayo Clinic in Minnesota. Dr. Pei-Ying Pai has been serving in China Medical University Hospital since 1989 and was the director of the division of cardiology and the director of the division of general internal medicine. In addition to rich experience, Dr. Pei-Ying Pai is kind and patient, and treat patients as family. Dr. Pei-Ying Pai specializes not only in the diagnoses and treatments of hypertension, heart failure and coronary artery disease (CAD), but also the implementation of heart ultrasound. He has completed more than 10,000 cases of ultrasound examination in recent years.

Dr. Ping-Han Lo specializes in different types of transcatheter interventions including coronary artery stent implantation, percutaneous coronary intervention (PCI) for chronic total occlusion (CTO), carotid artery stenting (CAS), percutaneous balloon dilatation of rheumatic mitral stenosis, catheter-assisted surgery for aortic stenosis (transcatheter aortic valve placement included), catheter ablation for hypertrophic cardiomyopathy, transcatheter closure of atrial septal defect in congenital heart disease, LAAC for stroke prevention in AF, PTA in uremic patients on hemodialysis and peripheral vascular stent insertion (renal artery, subclavian artery, iliac artery, femoral artery and vertebral artery)

Dr. Hsin-Yueh Liang had received 4-year echocardiography training in Mayo clinic and Johns Hopkins University in the United States and became a professional member in American Heart Association. Afterwards, she proactively promoted advanced echocardiography and was invited to deliver presentations on annual medical conferences. She performs about 2500 chest ultrasound examinations, 350 stress echocardiographies and 250 transesophageal echocardiographies every year. Since 2013, she has devoted herself to treating patients, utilizing the interventional transesophageal echocardiography, with other physicians specializing in cardiac catheterization. In 2017, she introduced the techniques of contrast-enhanced ultrasound to help CMUH link up with international standards in the echocardiography.

Dr. Chung-Ho Hsu specializes in various cardiovascular diseases, especially cardiac catheterization. Transcatheter cardiopulmonary interventional treatment include: 1) coronary balloon dilatation and stent placement, 2) carotid and peripheral vascular treatment, and 3) arrhythmia, radiofrequency electrical cautery and so on. The development of cardiac catheterization has led to the advancement of cardiovascular medicine and created many alternatives to surgery to reduce the suffering of patients with cardiovascular diseases and prolong the life of patients more effectively

Dr. Shih-Sheng Chang is a senior intervention cardiologist specializing in complex coronary artery disease and acute coronary syndrome. He serves as the Director of Interventional Cardiology and actively contributes to Taiwan‘s cardiology field as a board member of the Taiwan Society of Cardiology and director at the Myocardial Infarction Society. From 2022 to 2024, Dr. Chang furthered his expertise in AI applications in cardiology at NIH and Mayo Clinic, focusing on computer vision techniques to support diagnostic cardiology. Now leading the AI Center at China Medical University Hospital, he collaborates with physicians to develop patient-centered smart healthcare solutions. Recently, Dr. Chang was invited to present at the HIMSS Asia-Pacific Conference, sharing insights from his team’s innovations in smart healthcare.

Dr. Yu-Chen Wang is the Deputy Secretary-General of Taiwan's Interventional Cardiovascular Medical Association. Dr. Wang received a complete internal medicine and cardiology training at National Taiwan University Hospital. After completing her cardiology training in 2008, she joined the cardiovascular team in our hospital. Dr. Wang is currently a doctorate student at the Institute of Clinical Medicine, and from 2011 to 2012 he went to the Texas Heart Medical Center in the United States to study basic blood lipid and cell biology. Dr. Wang specializes in a wide range of heart diseases, including acute and chronic treatment of coronary artery disease and heart failure, including drug and cardiac catheterization. In addition, Dr. Wang also has a considerable degree of research on preventive medicine in heart disease, including prevention and treatment of hypertension, diabetes and hyperlipidemia. It is hoped that through the complete prevention and treatment, it will effectively enhance the treatment of various cardiovascular diseases so as to reduce the suffering of patients and prolong the life of patients.

Cardiovascular disease, pulmonary hypertension treatment Hypertension, hyperlipidemia Heart failure treatment